High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Top Cited Papers
Open Access
- 1 May 2010
- journal article
- practice guideline
- Published by Elsevier BV
- Vol. 21, v190-v193
- https://doi.org/10.1093/annonc/mdq187
Abstract
The incidence of malignant glioma is ∼5/100 000. Malignant glioma may develop at all ages, the peak incidence being in the fifth and sixth decades of life.Keywords
This publication has 33 references indexed in Scilit:
- IDH1andIDH2Mutations in GliomasThe New England Journal of Medicine, 2009
- Malignant Gliomas in AdultsThe New England Journal of Medicine, 2008
- Chemoradiotherapy in Malignant Glioma: Standard of Care and Future DirectionsJournal of Clinical Oncology, 2007
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trialActa Neurochirurgica, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical TrialJournal of Clinical Oncology, 2004
- Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsThe Lancet, 2002
- A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJournal of Neurosurgery, 2001
- Randomized Trial of Procarbazine, Lomustine, and Vincristine in the Adjuvant Treatment of High-Grade Astrocytoma: A Medical Research Council TrialJournal of Clinical Oncology, 2001